Orbital

Orbital Therapeutics aims to enhance global health by unlocking the full potential of RNA-based therapeutics (excluding RNAi therapies) to treat human diseases in ways that were previously impossible. The company is building a first-of-its-kind platform at the intersection of RNA technology delivery methods, data science, and automation to develop a broad portfolio of drugs, initially focused on vaccines, immunomodulation, protein replacement, and regenerative medicine. Founded by experts in genetic medicine and RNA development and delivery, Orbital has a dynamic operational structure designed to harness the ingenuity of a deep and diverse team of scientists, drug developers, and business leaders.